FDA approves 1st weight-loss pill
Digest more
MedPage Today on MSN
FDA Approves Wegovy Weight-Loss Pill
The FDA approved a pill version of the GLP-1 receptor agonist semaglutide (Wegovy), making it the first oral GLP-1 agent indicated for weight loss, Novo Nordisk announced on Monday.
Eli Lilly's oral pill helped maintain weight loss in patients switching from its GLP-1 injection, Zepbound, and rival Novo Nordisk's Wegovy, it said on Thursday, in a boost to deliver a more convenient obesity treatment option.